Xmark stake in Genaera continues to increase

By Lisa Kerner

Charlotte, N.C., July 12 - Xmark Opportunity Partners, LLC continued to build its stake in Genaera Corp. with the purchase of an additional 233,261 shares of the company's stock between June 29 and July 5, priced from $2.65 to $2.96 per share.

The reporting persons beneficially own 2,994,491shares, or 17.2%, of the company's outstanding stock, as stated in a schedule 13D filing with the Securities and Exchange Commission.

As previously reported, Xmark bought 186,221 shares of Genaera between June 26 and June 28 for a total of $478,809.15, raising its stake to 2,761,230 shares, or 15.8%.

On July 3, Xmark reported buying 330,548 shares for a total of $857,556.60, raising its stake to 2,575,009 shares, or 14.8%. Xmark bought those shares from May 25 to June 19 at prices from $2.4837 to $2.9807.

Genaera is a biopharmaceutical company based in Plymouth Meeting, Pa.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.